Systemic Exposure to Fluticasone Propionate Administered via Metered-Dose Inhaler Containing Chlorofluorocarbon or Hydrofluoroalkane Propellant

被引：0

作者：

Alison E. Mackie

Jo E. McDowall

Pietro Ventresca

Alan Bye

Christine Falcoz

Peter T. Daley-Yates

机构：

[1] Lilly Research Centre,Clinical Pharmacology

[2] Glaxo Wellcome Research and Development,undefined

[3] Glaxo Wellcome Research and Development,undefined

来源：

Clinical Pharmacokinetics | 2000年 / 39卷

关键词：

Fluticasone Propionate; Absolute Bioavailability; Chlorofluorocarbon; Urinary Cortisol; Urinary Cortisol Excretion;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：17 / 22

页数：5

共 50 条

[1] Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant
Mackie, AE
McDowall, JE
Ventresca, P
Bye, A
Falcoz, C
Daley-Yates, PT
CLINICAL PHARMACOKINETICS, 2000, 39 (Suppl 1) : 17 - 22
[2] Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: performance and patient satisfaction
Sheth, K.
Wasserman, R. L.
Lincourt, W. R.
Locantore, N. W.
Carranza-Rosenzweig, J.
Crim, C.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (10) : 1218 - 1224
[3] Pharmacokinetics of chlorofluorocarbon and hydrofluoroalkane metered-dose inhaler formulations of beclomethasone dipropionate
Lipworth, BJ
Jackson, CM
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (06) : 866 - 868
[4] Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects
Ruediger Nave
Karl Zech
Thomas D. Bethke
European Journal of Clinical Pharmacology, 2005, 61 : 203 - 208
[5] Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects
Nave, R
Zech, K
Bethke, TD
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (03) : 203 - 208
[6] Fluticasone propionate via the Diskhaler or hydrofluoroalkane-134a metered-dose inhaler on methacholine-induced airway hyperresponsiveness
Langley, SJ
Holden, J
Derham, A
Hedgeland, P
Sharma, RK
Woodcock, A
CHEST, 2002, 122 (03) : 806 - 811
[7] Systemic and pulmonary effects of fluticasone administered through a metered-dose inhaler in rats
Sorkness, RL
Remus, JL
Rosenthal, LA
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (05) : 1027 - 1032
[8] Delay Between Shaking and Actuation of a Hydrofluoroalkane Fluticasone Pressurized Metered-Dose Inhaler
Berlinski, Ariel
von Hollen, Dirk
Pritchard, John N.
Hatley, Ross H. M.
RESPIRATORY CARE, 2018, 63 (03) : 289 - 293
[9] Efficacy and safety of fluticasone propionate 44 μg/salmeterol 21 μg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment
Nelson, HS
Wolfe, JD
Gross, G
Greos, LS
Baitinger, L
Scott, C
Dorinsky, P
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2003, 91 (03) : 263 - 269
[10] Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered-dose inhaler
Dempsey, OJ
Wilson, AM
Coutie, WJR
Lipworth, BJ
CHEST, 1999, 116 (04) : 935 - 940

← 1 2 3 4 5 →